Stopping cancer from coming back is the goal of new research from MUSC Hollings Cancer Center, where scientists are targeting cells that fuel the return of an aggressive pediatric brain tumor.

Glioblastoma kills roughly 10,000 Americans every year. Patients diagnosed with a recurrence after standard chemotherapy face a median survival measured in months, not years, and the drug they rely on ...

Brain tumors are the leading cause of pediatric cancer-related death. In August, the Trump administration announced it would stop supporting a federally funded network dedicated to researching these ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the immune system better attack aggressive brain tumors in mice ...

Glioblastoma kills most patients within 15 months of diagnosis. It is the most aggressive brain cancer in young adults, and ...

Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and ...

The University of Virginia School of Medicine’s Harald Sontheimer and a colleague from Stanford University shared the Gertrud Reemtsma Foundation’s 2025 International Prize in Translational ...

For two years, 5-year-old Juliette Lesko has battled an incurable form of brain cancer, ependymoma. After enduring two brain surgeries, 30 sessions of radiation and two relapses, she is now being ...

Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The findings provide a clearer understanding of how these tumors develop, ...

A cruel consequence of advanced cancer is the profound apathy many patients experience as they lose interest in once-cherished activities. This symptom is part of a syndrome called cachexia, which ...